EGF and breast carcinoma: In breast cancer, the inhibition of the epidermal growth factor (EGF), nuclear factor kappa B (NF-kB), ERK/Akt, and MMP 2 and 9 signaling pathways due to ECS activation results in anti-proliferative effects [49].